Differential gene expression in two established initiation and promotion skin carcinogenesis models during promotion and tumor formation was determined by microarray technology with the purpose of distinguishing the genes more associated with neoplastic transformation from those linked with proliferation and differentiation. The first model utilized dimethylbenz [a]anthracene initiation and 12-O-tetradecanoylphorbol 13-acetate (TPA) promotion in the FVB/N mouse, and the second TPA promotion of the Tg.Ac mouse, which is endogenously initiated by virtue of an activated Ha-ras transgene. Comparison of gene expression profiles across the two models identified genes whose altered expression was associated with papilloma formation rather than TPA-induced proliferation and differentiation. DMBA suppressed TPA-induced differentiation which allowed identification of those genes associated more specifically with differentiation rather than proliferation. EASE (Expression Analysis Systemic Explorer) indicated a correlation between muscleassociated genes and skin differentiation, whereas genes involved with protein biosynthesis were strongly correlated with proliferation. For verification the altered expression of selected genes were confirmed by RT-PCR; Carbonic anhydrase 2, Thioredoxin 1 and Glutathione S-transferase omega 1 associated with papilloma formation and Enolase 3, Cystatin b and Filaggrin associated with TPA-induced proliferation and differentiation. In situ analysis located the papillomas Glutathione S-transferase omega 1 expression to the proliferating areas of the papillomas. Thus we have identified profiles of differential gene expression associated with the tumorigenesis and promotion stages for skin carcinogenesis in the mouse.
Introduction
Murine models of skin carcinogenesis require an activating mutagenic event followed by multiple applications of an agent that induces clonal expansion (promotion) of the mutated cells to form tumors. Two mouse models were utilized that are widely used to study the molecular mechanisms of initiation and promotion in skin carcinogenesis. In the first, a single dose of carcinogen is followed by multiple doses of a promoting agent (1, 2) . In the second model, the Tg.Ac mouse carries an activated Ha-ras transgene, and requires only promotion to form papillomas (3) . The papillomas that develop in both models are histopathologically similar. The phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) acts as an efficient promoting agent in these models by inducing homogeneous proliferation and differentiation of mouse skin cells, some of which are the progenitors for papillomas (3) (4) (5) . Cells that are not initiated proliferate and differentiate when affected by TPA but upon TPA withdrawal do not progress to unregulated division (3, 6) . There is therefore a pathologically distinct phase of proliferation and differentiation prior to the formation of papillomas (3) . This response to promotion results in the differential expression of many genes within the initiated cells prior to papilloma formation (7, 8) . It is not clear whether these alterations are necessary for the formation of papillomas or associated with proliferation and differentiation only.
Microarray technology has greatly facilitated the study of differential gene expression and allowed large-scale determination of gene expression changes associated with tissue changes and tumor formation. In the skin, microarrays have previously been used to study the basal gene expression of mouse strains that are sensitive or resistant to skin carcinogenesis (9) , and to examine differential gene expressions associated with the effects of UV irradiation on keratinocyte wounding (10) . Several studies have examined genes differentially expressed in C57BL/6 and NMRI mouse skin in response to a single dose of TPA and in isolated cells from Tg.Ac mice treated with multiple doses of TPA (7, 8, 11, 12) . The purpose of this study was to characterize differential gene expression in murine skin carcinogenesis models by comparing FVB/N and Tg.Ac mouse skin prior to, and after, the formation of papillomas. For the classic initiator and promoter protocol using dimethylbenz [a] anthracene (DMBA) initiation and TPA promotion (13) FVB/N mice were chosen as these have the same genetic background as Tg.Ac mice. Tg.Ac mice require only promotion with TPA. Further analysis was applied to classify whether gene changes were associated with either the tumor formation or the hyperproliferative and differentiation response to promotion by TPA. By comparing common gene expression changes in the two models of skin carcinogenesis we sought to demonstrate the association of these genes with tumor formation in the skin.
Materials and methods

Animals
Female FVB/N and Tg.Ac (hemizygotes) mice 3-5 weeks of age were purchased from Harlan UK and Taconic UK, respectively. The mice were contained in an isolator and maintained at 19 C with 50% relative humidity and a 12-h light-dark cycle. Following a 1 week acclimatization period the dorsal skin of the mice was shaved using clippers (approximately 8 cm 2 area) 2 days prior to commencing topical treatments. FVB/N mice (five per group) were treated with DMBA (10 mg/200 ml in acetone) or vehicle control 1 week before promotion with TPA. FVB/N and Tg.Ac mice (five per group) were treated with TPA (2.5 mg/200 ml in acetone) twice a week for up to 14 weeks; control mice received acetone. All chemicals were applied topically using a pipette. Mice were shaved and examined weekly for the presence of papillomas. At each time point the mice were killed by cervical dislocation and the dorsal skin removed, a representative portion was fixed in 10% neutral buffered formalin for 1 week and processed conventionally, sectioned and stained with haematoxylin and eosin. The remainder of the tissue was snap frozen in liquid nitrogen.
Proliferation measured by PCNA immunohistochemistry Mouse skin sections (5 mm) were cut, dewaxed and taken to water. Antigen retrieval was performed by microwaving at 700 W for 20 min in 0.01 M citrate pH 6. The primary antibody to Proliferating Cell Nuclear Antigen (Novocastra, Newcastle upon Tyne, UK, NCL-PCNA) was used at a dilution of 1:100 and applied to the sections for 3 h at room temperature. Serial control sections were treated similarly, with the primary antibody replaced by negative control mouse IgG2a (DAKO, Cambridgeshire, UK X0943). The primary antibody was detected using a peroxidase-labelled anti-IgG2a antibody (Serotec, Oxford, UK, STAR82P). The peroxidase was detected using 3,3-diaminobenzidine tetrahydrochloride, with the sections lightly counterstained with haematoxylin. The number of cells staining positive for PCNA were counted in five different fields for each section. The average number of stained cells per field was calculated for each treatment. Statistical significance was calculated using a two-tailed unpaired Student's t-test.
RNA extraction
Approximately 500 mg of tissue was homogenized on ice in Tri reagent (2 ml) using an Ultraturrax blender and chloroform/isopropanol extraction was performed twice. During the second round of extraction an extra chloroform extraction step was added to ensure the RNA was free from lipophilic contaminants.
Microarrays
To construct the cDNA microarrays, Expressed Sequence Tag (EST) clones were obtained from the IMAGE collection (MRC Geneservice, Cambridge, UK) and amplified by PCR. The DNA was printed in betaine (14) onto poly-Llysine coated slides. Prior to use the slides were baked for 2 h at 80 C, washed in two changes of 0.2% SDS and two changes of water before being denatured by baking at 100 C for 2 min. Labelling and hybridization reactions were carried out as previously described (15) except that Microcon YM30 columns (Millipore, Massachusetts, USA) were used to purify the final reaction products and the slides were prehybridized as previously described (16) . In some experiments repeat hybridizations were carried out with reversal of the fluorescent dyes. Where the amount of RNA was limiting, 5 mg of RNA was labelled using Genisphere 3DNA
Ò array 350Ô labelling kits (InterVascular, Cedex, France) following the manufacturer's instructions. After hybridization for at least 16 h at 42 C in a 50% formamide buffer the slides were washed as described by (15) and the fluorescence was measured using GenePix version 3.0 software (Axon Instruments, CA, USA). Microarray data are available on Arrayexpress (http:// www.ebi.ac.uk/arrayexpress/) using the accession numbers E-MEXP-188, A-MEXP-98, A-MEXP-99, A-MEXP-100 and A-MEXP-101.
Samples were hybridized to microarrays as follows: (i) TPA-treated only (T) against DMBA/TPA (DT) with the purpose to identify tumor-associated genes. This comparison was designed to cancel out any effect of proliferation, differentiation or TPA exposure; (ii) DMBA only (D) against DMBA/TPA (DT) to identify those genes both tumor, proliferation-and differentiation-associated; and (iii) Tg.Ac control against Tg.Ac TPA-treated. This combination was designed to confirm the data obtained from the FVB/N DT mice in a different model with a different initiation protocol.
Normalization and statistical analysis
Median pixel-fluorescent intensity data from each array feature were collected and the local background was subtracted prior to analysis. Data were normalized by a global normalization procedure. Background was not subtracted as this had been established to have a detrimental effect on the data (Zhang and Gant, personal communication). Fluorescence data from each array feature were retained in the data set if positive with respect to the background. A threshold cut-off was not used except where there existed fluorescent data in only one channel. These data were retained in the data set if the intensity of fluorescence in the single channel was greater than 40% of the mean channel value. After normalization, the ratio of hybridization between the control and treated samples (where there existed fluorescent values for both channels) was calculated and statistical analysis of the results performed according to the methods described by (17) . All genes that were significantly altered (P 0.05) in expression in at least one sample of the time course were clustered using hierarchical clustering (Cluster 3, University of Tokyo, Human Genome Centre). EASE (Expression Analysis Systemic Explorer) analysis was performed using bootstrapping with 10 000 iterations on the individual gene sets associated with the pathological changes (18) .
Real time-PCR (RT-PCR)
RNA (400 ng) was reverse-transcribed using Superscript II (Invitrogen, Paisley, UK) and the resulting cDNA was used for amplification with SYBR Ò green mastermix (Applied Biosystems, Warrington, UK). Reactions were carried out on an ABI PRISM Ò 7700 RT-PCR machine using optimized primers. Primers for RT-PCR were designed using Primer Express Ò software v2.0 (Applied Biosystems, Warrington, UK). The sequences used were: Car2: forward, CAAGCACAACGGACCAGAGAA, reverse, GGGCAGTTGCTGT-GTCAATGT; Cryab: forward CGGAGGAACTCAAAGTCAAGGT, reverse ATCCGGTACTTCCTGTGGAACTC; Cstb: forward, CCGTGCTACCC-CGACTACTG, reverse, CAAACTTCTGATTTTCTTTCGATTCA; Eno3: forward, GCTCCGTGACGGAGTCCAT, reverse, AGCGGTGGCTCACC-ATCA; Flg: forward, AACACTGAGCAAAGAAGAGCTGAA, reverse, CAGCGAAATCTAGTTTGTCATCGT; Gsto1, forward, CAGCGACTGGA-AGCATTGG, reverse, CCGCCATCCAGAGCTTGA; Txn1, forward, TTCC-TTGAAGTGGACGTGGAT, reverse, CTCACCTTTTGACCCCTTTTTAT-AA and Inv, forward, GAGCGTGAAGGTTATCAAGGA, reverse, TGCT-GCTGCTTCTCTGTAGTG. The expression level of the gene of interest was normalized to that of Cyclophilin A in all samples. Statistical significance of the data was assessed by two-tailed t-test assuming unequal variance.
In situ hybridization A plasmid containing a Gsto1 (Accession number AV006756) insert was used to make a single stranded RNA probe labelled with biotin by incorporation of biotin-16-UTP (Roche, Penzberg, Germany). The reactions were purified using Microcon YM30 columns (Millipore, MA, USA) and alkaline digested with an equal volume of 100 mM sodium carbonate pH 10.2 for 71 min at 60 C. Following digestion, probes were neutralized with an equal volume of 0.2 mM sodium acetate, 1% glacial acetic acid (v/v), 10 mM dithiothreitol and precipitated overnight with sodium acetate and ethanol at À20
C. An ELF Ò 97mRNA In Situ Hybridization kit (Invitrogen, Paisley, UK) was used to detect expression in paraffin-embedded skin sections (4 mm) on 3-aminopropyltriethoxysilane (APES)-coated slides. The manufacturer's instructions were followed for section preparation prior to, and after hybridization of the probe (10 ng), or no probe negative control. Prehybridization and hybridization conditions were as described for microarray experiments. Fluorescence was visualized using an Axioskop fluorescence microscope (Zeiss, Germany) and pictures were taken using a ProgRes C14 camera (Jenoptik, Jena, Germany). development occurred much faster in Tg.Ac mice and with a higher multiplicity leading to their termination after 9 weeks of promotion. Papillomas only formed in FVB/N mice that were both initiated and promoted ( Figure 1A ) as expected. Despite the altered latency and tumor burden very similar welldifferentiated tumors were generated in both strains of mice. Due to the difference in papilloma latency time between the Tg.Ac and FVB/N, mice skin was isolated at different times in the two strains prior to the formation of papillomas. The time points were compared with each other by reference to papilloma formation rather than by absolute time from the commencement of promotion. Therefore, the Tg.Ac and FVB/N skin isolated 4 days and 2 weeks, respectively after commencing promotion were comparable in terms of length of time prior to papilloma formation. This was also true for Tg.Ac mice skin isolated after 1, 2 and 9 weeks and FVB/N skin isolated after 4, 6 and 14 weeks of promotion. The timescale of the sample collection for FVB/N is shown in Figure 1B and for Tg.Ac in Figure 1C Figure 2L ). The increase in the layers of flattened cells (arrows) containing keratohyaline granules in these skins also suggested a differentiation response to TPA ( Figure 2B inset). The proliferative response to TPA was greater at 2 weeks in those mice initiated with DMBA prior to TPA treatment compared with TPA treatment alone, and similar at both 4 and 6 weeks ( Figure 2L ). Though proliferation was greater in the mice initiated with DMBA prior to TPA treatment, than in TPA alone, at 2 weeks the extent of differentiation was not as marked ( Figure 2E inset) . This DMBA mediated decrease in differentiation response to TPA was confirmed by Involucrin ( Figure 2M ) and Filaggrin ( Figure 3B ) expression which are both markers of keratinocyte terminal differentiation (19, 20) . Expression of these genes was reduced in the skin of mice initiated with DMBA prior to TPA treatment compared with those that received TPA alone. The TPA-only treated Tg.Ac and FVB/N mice showed similar proliferation responses ( Figure 2I to K and Figure B to D). This was also true at the 14 (FVBN) and 9 week (Tg.Ac) time points when papillomas were present ( Figure 2L ).
Genomic analysis
In non-transgenic mice TPA treatment without prior initiation induced proliferation and differentiation, but did not lead to papilloma formation (Figure 1 and 2 ). Therefore, a microarray analysis of FVB/N mouse skin that had been initiated with DMBA and promoted with TPA would be complicated by gene expression effects caused either by the TPA directly or by the proliferative and differentiation response in the keratinocytes. To identify these changes two different microarray comparisons were made using FVB/N mouse skin. In the first comparison TPA-promoted skin (T) was compared with DMBA-initiated and TPA-promoted skin (DT). This comparison was designed to cancel out the effects of TPA exposure and so reveal those genes more closely associated with tumor formation. In fact as illustrated in Figure 2 the comparison cannot be absolute as DMBA had the effect of reducing the differentiating response of keratinocytes to TPA determined by Filaggrin ( Figure 3B ) and Involucrin ( Figure 2M ) expression. The second comparison was made between DMBA-initiated skin (D) and skin that was both DMBA-initiated and TPApromoted (DT). This comparison generated a mixed response where gene expression changes could be associated with tumor formation, proliferation, differentiation or TPA exposure. For further discernment of gene designation, comparison was also made with the Tg.Ac experiment, where the gene expression responses to differentiation and tumorigenesis should be similar to FVB/N mice. In addition, in this experiment, we took a 4 day sample where direct responses to TPA may be more pronounced.
Genes were chosen for inclusion in Figure 3 if there was at least one time point where a gene showed a differential expression with a significance of P 0.05. In total this gave 617 genes for multivariate analysis. The significance criterion used is relatively low with a potentially larger than desirable false positive rate. However, because of the nature of the experimental comparison this was the optimal method for selecting the genes to go forward for analysis. After selection of the genes various methods of grouping were tried including self-organizing maps and principal components analysis. However, in common with many analyses of this nature, hierarchical clustering with complete linkage was found to yield the Gene expression associated with murine skin tumors Fig. 3 . Cluster analysis of promotion and tumor-associated gene expression. FVB/N mice were treated with DMBA (10 mg) 1 week prior to commencing TPA or acetone vehicle control treatment (DT or D, respectively). Control FVB/N mice that received acetone instead of DMBA were also treated with TPA (T). Tg.Ac mice were treated with TPA or acetone vehicle control for the indicated times. Microarray comparisons were carried out between FVB/N D/DT and T/DT. Tg.Ac sample comparisons were made between acetone and TPA-treated skins, indicated just as Tg.Ac. All genes that were significantly altered (P 0.05) in expression in at least one sample were clustered using hierarchical clustering (GeneCluster 3.0). The central panel shows a treeview visualization (either MapleTree (0.2.3.2 Beta or treeview 1.5 (http://rana.lbl.gov/EisenSoftware.htm). The highest density of colour is associated with a 4-fold (log 2 =2) or more differential regulation, mauve is upregulated and blue downregulated with respect to the ratio as shown in the header or in the case of Tg.Ac animals it is the TPA-treated over the control (acetone-treated). Clusters associated with differentiation, associated as described in the text, are shown in panels A-D with those primarily downregulated in response to differentiation in panels A and C, and those upregulated in panels B and D. Differential gene expression associated more with tumor and tumor formation, associated as described in the text, is shown in panels E-K. Panels E, F and I are genes increased in expression in response to tumor formation and those in panels G, H and J are downregulated. Panel K shows genes biochemically associated with increased translation in response to the tumor process. Gene symbols are associated with names in Table II .
most interpretable data. The clustering of the whole 617 genes is shown in Figure 3 and from this individual clusters were selected based on the pathological criterion. The clusters in Figures 3A-D show genes whose differential expression was primarily associated with differentiation. The criterion for this selection was an inverse gene expression response in the T/DT experiments compared with the Tg.Ac and D/DT experiments. The reason was that the differentiation response to TPA was partially inhibited by DMBA indicated by the decreased Involucrin ( Figure 2M ) and Filaggrin ( Figure 3B (21) . Cluster E shows upregulated genes as do F and I; though in F the response in the 14 week D/DT samples is less marked than that in the 9 week Tg.Ac and in cluster I the converse. Clusters G, H and J show downregulated genes. The downregulated genes shown in clusters H and J were though not equivalent in the 9 week Tg.Ac and 14 week D/DT samples as they were in cluster G. This may have been due to sample selection or not exact matching of the stage of tumorigenesis between the two models. Cluster K is differentiated from the others in this group by time. The alterations in gene expression through the three samples are similar indicating that these are associated with tumor formation rather than other pathological changes in the skin. However, the responses are occurring very early in the time course and decreasing in the tumor-bearing samples (9 week Tg.Ac and 14 week D/DT). This strongly suggests a differential gene expression in response to a change in biochemical homeostasis. Many of the genes in this cluster are ribosomal. It is therefore feasible that translation is changing in the skin which could be related to the synthesis of proteins for proliferation, differentiation and tumor formation. EASE analysis confirmed this hypothesis (Table I) showing a strong correlation of genes associated with protein biosynthesis with the proliferation.
RT-PCR confirmation of microarray findings
Genes indicated in red on Figure 3 were representative for a given cluster and their expression changes confirmed by RT-PCR. In Figure 4A , RT-PCR verification of differential gene expression is shown for seven genes from the differentiation-associated (patterned bars) and carcinogenesis (solid bars) associated sets. Verification was performed at two time points, for the FVB/N mouse experiment weeks 2 and 14, and also week 9 and dissected tumor from the Tg.Ac mice. Although the time points were selected on the basis of no papilloma formation; proliferation and differentiation had occurred during week 2 and papilloma formation during week 14 FVB/N and week 9 Tg.Ac. The tissue used from the week 14 FVB/N and week 9 Tg.Ac mice contained both papillomas and surrounding skin. Those genes which were assigned as differentiation-associated Eno3, Cstb, Flg and Cryab ( Figure 4A 
In situ analysis
The location of Gsto1 in the papillomas was determined using in situ analysis ( Figures 5A and B) and compared with the localization in untreated skin ( Figure 5C ). Expression was predominant in the proliferating area of the papillomas. In the normal skin some expression was detectable in the suprabasal layers ( Figure 5C ). At higher power, expression could be seen it in the upper hair follicles ( Figure 5D ).
EASE analysis
To discern if there were any particular gene classes that were significantly associated with the process of proliferation or differentiation the genes associated in Figure 3 with these processes were submitted for analysis using EASE (18) . The predominant classes associated with each set of genes are shown in Table I . The main class of genes associated with the skin differentiation were members of the myosin Figure 3 panels A-D against those in panels E-K. Bootstrapping was performed with 10 000 iterations and the sets with an EASE score of less than 0.05 are shown. For clarity the actual gene annotations in each set have been left out of the table.
Gene expression associated with murine skin tumors family which are generally associated with muscle development (mybpc2, myh7 ( Figure 3A) , myh3, myl1 and myl4 ( Figure 3C) ). For the proliferation-associated genes (Figure 3) , the main gene association was with the classes of genes linked by a functional association with protein synthesis. As we had defined these genes as being associated with proliferation, it was not altogether surprising to find that these were the main classes of genes overrepresented. Of the three genes that were particularly characterized, Gsto1 in downstream analysis has not been previously associated with proliferation and tumorigenesis in the skin.
Discussion
FVB/N and Tg.Ac mice are established mouse models widely used to study skin carcinogenesis. This investigation was undertaken to identify genes whose differential expression was more closely associated with the pathological phases of keratinocyte proliferation, differentiation and papilloma formation. Though association of these cannot be absolute as tumor tissue is by definition proliferating, it was possible to identify gene clusters more closely associated with each pathological phase. In particular, the genes associated with the tumor formation were more evident. It is theoretically possible that the differential gene expression observed could be due to inflammatory infiltrate. However, little inflammation was observed pathologically or indicated by the differential gene expression. It seems more likely therefore that the differential gene expressions measured here reflect changes in the keratinocytes. Initiated and promoted FVB/N and promoted Tg.Ac mice responded as expected to the dosing regimes employed (Figure 1 ). The average number of papillomas per mouse and latency time to first papilloma appearance in the Tg.Ac mice were comparable with results reported previously (22) . The FVB/N mice in this study showed a comparable papilloma burden to that reported by Battalora (13) using a similar treatment schedule (Figure 1 ). Epidermal proliferation and differentiation was present in all mice that had been promoted irrespective of initiation and was evident as early as 2 weeks after the start of promotion as has been reported previously (23) ( Figure 2B ). However, differentiation was enhanced in TPA-treated skin compared with DMBA-and TPA-treated skin, and was manifest by the appearance of flattened cells containing prominent keratohyaline granules, and a marked induction of Involucrin and Filaggrin gene expression (24) . This response was not unexpected as initiated cells are known to escape differentiation.
Differentiation-associated genes
Those genes identified as being changed in expression in a manner associated with differentiation were generally altered at early time points and remained differentially expressed through to tumorigenesis ( Figure 3A-D) . The altered expression of Eno3, Cstb and Flg have previously been recorded in response to differentiation induced by TPA (12, (25) (26) (27) (28) . A decrease in Eno3 expression has been demonstrated in mouse skin 6 h after TPA treatment (12) . Eno3 was consistently reduced in expression throughout the time course of this study, and was classified as a proliferation and differentiation responsive gene ( Figure 3A and 4A) . Eno3 is the musclespecific form of enolase, associated with glycolysis and inherited recessive metabolic myopathy in humans (29) . Therefore, decreased expression of Eno3 may be associated with its role in glycolysis, and potentially suggests a reduced requirement for energy in the differentiating skin. EASE analysis demonstrated an interesting correlation though of skin differentiation with the expression of muscle-specific genes (Table I) in particular members of the myosin family and Eno3. There has been a previous association of myosin expression with dermatofibromas and it could be that the smooth muscle proteins are specific markers for differentiating as opposed to proliferative skin lesions (30). Gap junction membrane channel protein beta 1 S100a10 S100 calcium binding protein A10 (calpactin) Ltbp3
Latent transforming growth factor beta binding protein 3 Ddah1
Dimethylarginine dimethylaminohydrolase 1 Xrcc5 X-ray repair complementing defective repair in Chinese hamster cells 5 Igh AT rich interactive domain 3A Chemokine (C-C motif) ligand 6 Gpx3
Glutathione peroxidase 3 Ifi203
Interferon inducible protein 203 Thbs2
Thrombospondin 2 K. Rps11
Ribosomal protein S11 Gtf2b
General transcription factor IIB Rps3
Ribosomal protein S3 Rps9
Ribosomal protein S9, Rplp2
Ribosomal protein, large P2 Cd3g CD3 antigen, gamma polypeptide, Rpl11
Ribosomal protein L11 Rpl9
Ribosomal protein L9 Rpl5
Ribosomal protein L5 Rps3a
Ribosomal protein S3a Rps26
Ribosomal protein S26
For clarity only the HUGO gene symbols have been shown in Figure 3 . The complete gene name is given here in the same order as Figure 3 .
Gene expression associated with murine skin tumors Both Cstb and Flg are associated with keratinocyte differentiation and found in the cornified envelope (25) (26) (27) (28) . Commensurate with this Flg is also known to be increased during calcium-induced differentiation of skin cells (26, 28) and in response to TPA and v-ras transfection. Homologues of Cstb have been demonstrated to be crosslinked to Flg by transglutaminase, a process that occurs in cornified envelope formation. Cstb homologues are also elevated in expression during wound healing (11, 31) . Thus, the alteration in expression of these two genes with differentiation and proliferation as seen in this study is entirely consistent with the known functional roles for these genes in skin. Reduced expression of the chaperone protein Cryab was consistent in both strains of mice across the time course studied ( Figure 3A and 4A) . The elevation of Cryab expression has been associated with resistance to the effects of DNA-damaging drugs (32) , and reduced Cryab expression in epithelial ovarian cancer correlates with reduced median survival time (33) .
Tumor and proliferation-associated genes Tumor and proliferation-associated genes were primarily defined by their differential expression in the tumor-bearing skin samples and are shown in Figure 3 (E-K). EASE analysis of this gene set (Table I) primarily identified genes associated with protein synthesis. Given that these genes had been selected on the basis of their differential expression in tumorbearing samples; this is perhaps not a surprising association. For further analysis we chose three genes whose differential expression was strongly associated with tumor formation, but were not included in the EASE analysis of genes associated with protein synthesis. Increased expression of the tumorassociated gene Txn1 was small ( Figure 3E ) when assessed by microarray analysis. We chose to investigate this gene further because of its known cancer association. Using RT-PCR we further corroborated significant changes in the expression of Txn1 in 9 weeks promoted Tg.Ac skin. DMBA and TPA have previously been demonstrated to increase the activity of Txn1 (34). Thus, it may be that Txn1 induction is partly modulated by both proliferation/differentiation and cancer-associated mechanisms. Txn1 was elevated in the three samples containing papillomas that were analysed by RT-PCR ( Figure 4A ). There are conflicting reports on the effect of Txn1 expression on cell growth. Recombinant Txn enhances the growth of NIH3T3 cells, whereas in HeLa, Txn1 is required for interferon g-mediated growth inhibition (35, 36) . In mice, a 2-fold overexpression of Txn1 leads to an increase in papilloma formation with the DT protocol (21). Immunostaining has shown Txn1 in differentiated squamous cell carcinomas (37) and expression has been found to be increased in gastric carcinomas (38) .
Car2 and Gsto1 gene expression was markedly increased in expression during the course of these studies, as demonstrated both by microarray analysis and RT-PCR. The mRNA levels of Car2 were altered in both a promotion-dependent (early time points) and a skin papilloma-associated manner. The possibility of a Car2 role in skin cell differentiation in response to TPA promotion is appealing as Car2 is present in differentiated osteoclasts. It is induced by differentiation stimuli and inhibited when terminal differentiation is abrogated (39) (40) (41) . However, here the changes in Car2 levels were associated with papilloma formation (Figure 4A) , and therefore the control stimuli may be different. Strongly associated with the formation of the skin tumors was increased expression of Gsto1 ( Figures 3E, 4A and B) . In situ analysis clearly showed the expression of this gene within the proliferative areas of the papillomas ( Figure 5A and B) . Although Gsto1 is classified as a Gst, this isoform not only has weak Gst activity, but also possesses other thiol transferase (42) and dehydroascorbate reductase (43) activities more widely associated with glutaredoxins. Dehydroascorbate reductase activity may be pertinent to the skin as several in vitro studies have shown that ascorbate or its stable derivative AA-2P cause keratinocyte cell differentiation, protect against UV-induced cell damage and enhance production of lipids associated with the cornified envelope (44) (45) (46) . In a survey of human tissues, Gsto1 was only found expressed within the macrophages of the skin (47) . However, it is unlikely that macrophages are solely responsible for the Gsto1 detected within the skin in this study, as we did not see an inflammatory infiltrate either within papillomas or hyperplastic skin. Gstpi, another member of the GST family has been shown to function as a tumor suppressor in skin carcinogenesis experiments and Gstpi null mice show enhanced sensitivity to chemically induced skin tumorigenesis (48) . We did not see increased expression of Gstpi, though there was an increased expression of Gsta1, which showed a similar expression profile to that of Gsto1.
Generally increased in expression through the time course to tumor formation in all comparisons were members of the ribosomal family such as Rpl11. The increased expression of these genes would indicate a general increase in translation and protein synthesis. These genes were primary contributors to the EASE identification of gene classes associated with protein synthesis (Table I) . Previously there have been reports of increased translation in response to TPA, e.g. of the elongation factors, and this would not be unexpected; given the proliferation response and the increased need for protein (49) .
In summary, this work has identified some genes differentially expressed and associated with the general effects of tumor promotion and differentiation in the skin, and others more closely associated with papilloma formation in FVB/N and Tg.Ac mice. Some of these were altered prior to the formation of papillomas and were associated with papilloma formation. The association of Gsto1, Cryab and Car2 with tumor formation suggests a potentially fundamental role for these proteins in the process of tumor formation and development.
